Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP884741.RAZu2Jug1AoDTz0cs2ehcLxya2v1B23ZqBStXU2mylOqM130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP884741.RAZu2Jug1AoDTz0cs2ehcLxya2v1B23ZqBStXU2mylOqM130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP884741.RAZu2Jug1AoDTz0cs2ehcLxya2v1B23ZqBStXU2mylOqM130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP884741.RAZu2Jug1AoDTz0cs2ehcLxya2v1B23ZqBStXU2mylOqM130_provenance.
- NP884741.RAZu2Jug1AoDTz0cs2ehcLxya2v1B23ZqBStXU2mylOqM130_assertion description "[In addition, antigen-specific CD4+ T cells from hybrid peptide immunized DR4-IE Tg mice synergized with HER-2/neu(435-443)-specific CD8+ T cells from HLA-A2.1 Tg HHD (H-2b) mice in producing antitumor immunity into SCID mice xenografted with the HER-2/neu+, HLA-A2.1+ and HLA-DR4+ FM3 human melanoma cell line.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP884741.RAZu2Jug1AoDTz0cs2ehcLxya2v1B23ZqBStXU2mylOqM130_provenance.
- NP884741.RAZu2Jug1AoDTz0cs2ehcLxya2v1B23ZqBStXU2mylOqM130_assertion evidence source_evidence_literature NP884741.RAZu2Jug1AoDTz0cs2ehcLxya2v1B23ZqBStXU2mylOqM130_provenance.
- NP884741.RAZu2Jug1AoDTz0cs2ehcLxya2v1B23ZqBStXU2mylOqM130_assertion SIO_000772 17634957 NP884741.RAZu2Jug1AoDTz0cs2ehcLxya2v1B23ZqBStXU2mylOqM130_provenance.
- NP884741.RAZu2Jug1AoDTz0cs2ehcLxya2v1B23ZqBStXU2mylOqM130_assertion wasDerivedFrom befree-20150227 NP884741.RAZu2Jug1AoDTz0cs2ehcLxya2v1B23ZqBStXU2mylOqM130_provenance.
- NP884741.RAZu2Jug1AoDTz0cs2ehcLxya2v1B23ZqBStXU2mylOqM130_assertion wasGeneratedBy ECO_0000203 NP884741.RAZu2Jug1AoDTz0cs2ehcLxya2v1B23ZqBStXU2mylOqM130_provenance.
- befree-20150227 importedOn "2015-02-27" NP884741.RAZu2Jug1AoDTz0cs2ehcLxya2v1B23ZqBStXU2mylOqM130_provenance.